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Abstract
In recent years there has been much interest in the use of optical diagnostics in cancer detection. Early diagnosis
of cancer affords early intervention and greatest chance of cure. Raman spectroscopy is based on the interaction of
photons with the target material producing a highly detailed biochemical ‘fingerprint’ of the sample. It can be
appreciated that such a sensitive biochemical detection system could confer diagnostic benefit in a clinical setting.
Raman has been used successfully in key health areas such as cardiovascular diseases, and dental care but there is
a paucity of literature on Raman spectroscopy in Head and Neck cancer. Following the introduction of health care
targets for cancer, and with an ever-aging population the need for rapid cancer detection has never been greater.
Raman spectroscopy could confer great patient benefit with early, rapid and accurate diagnosis. This technique is
almost labour free without the need for sample preparation. It could reduce the need for whole pathological spe-
cimen examination, in theatre it could help to determine margin status, and finally peripheral blood diagnosis may
be an achievable target.
Introduction
In recent years there has been much interest in the use
of optical diagnostics in cancer detection. At present a
diagnosis of cancer is made on histological evaluation
with possible prior cytological evidence. In some cases
definitive diagnosis is only made on resection of the
tumor, as prior interventions have been equivocal. Early
diagnosis of cancer affords early intervention and great-
est chance of cure. The ability to detect early biochem-
ical changes associated with carcinogenesis prior to the
changes a pathologist identifies would revolutionize can-
cer diagnostics.
Infrared spectroscopy, along with other optical techni-
ques such as elastic scattering spectroscopy, differential
path-length spectroscopy, fluorescence techniques, and
optical coherence tomography have been assessed in the
detection of head and neck tumors [1,2]. These have all
provided encouraging results; Raman spectroscopy is in
the early stages of development in relation to life
sciences and this article aims to review the literature
regarding its application to head and neck cancer.
Background
The Raman Effect was first discovered by Professor
Raman of Calcutta University for which he was awarded
the Nobel prize in 1930 [3]. This effect is based on light’s
interaction with matter; as photons are directed towards
target matter, most will pass through unchanged. How-
ever, some photons will come into contact with mole-
cules in the matter. Most of these photons will interact
with the molecules of the substance, exciting the particles
to a partial quantum state, with the emission of a photon
at the same frequency as the incident photon [4]. This
process is known as elastic scattering. A smaller number
of these (approximately 1 in 106 to 1 in 108) photons will
undergo a process called Raman or inelastic scattering.
The photon is discharged from the material or ‘scattered’
at a differing wavelength than the incident photon and it
is this wavelength shift which is recorded in Raman
spectroscopy.
Raman spectroscopy is highly specific and affords the
ability to take recordings from very small sections of the
target sample (figure 1). The interaction of the photons
with the target material produces a detailed biochemical
‘fingerprint’ of the sample that is characteristic for the
constituent chemical bonds (figure 2). It can be appre-
ciated that such a sensitive, high resolution biochemical
detection system could confer diagnostic benefit in a
clinical setting. The upper aerodigestive tract is generally
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Figure 1 A thyroid cell under the microscope attached to the Raman system. This picture highlights the resolution of the Raman system,
as measurements can be taken (at the cross-hairs) from a small section of a single cell (1 micro-metre squared area).
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Figure 2 Raman spectra taken from a single thyroid cell, depicting multiple ‘spikes’ attributable to biochemical species within the
cell. Some of the chemical bonds have been labeled for identification.
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more easily accessible than other regions of the body,
allowing detection systems to be used in office or com-
munity settings. A Raman based diagnostic system could
not only afford early tissue analysis of a solid tumour
but also the possibility of detecting biochemical changes
within peripheral blood of patients with cancer.
Literature
Harris et al. (2009) studied the ability of Raman spectro-
scopy to discriminate between two thyroid cell lines [5].
These were commercial cell lines; one of a non-cancer
lineage and the other an anaplastic carcinoma cell line
(figures 3 and 4). Raman spectroscopy coupled with neural
network analysis gave 95% sensitivity for the anaplastic
cell line and 92% for the non-cancerous cell line. Follow-
ing on from these encouraging results the authors’ further
tested the system using five thyroid cell lines including;
non-cancerous, papillary carcinoma, follicular carcinoma,
medullary carcinoma and anaplastic carcinoma [6]. This
time Raman spectroscopy was coupled with genetic algo-
rithms for data analysis. Results demonstrated a relatively
poor discrimination (sensitivity 61%) between cell lines of
a similar genotype and ultimately phenotype, such as non-
cancerous versus papillary carcinoma but when cells from
opposing ends of the biological spectrum were tested such
as non-cancerous versus medullary or anaplastic carci-
noma, the results were much better (88% and 91% respec-
tively). The authors are taking forward this work with
testing of the algorithm using actual tissue samples.
In 2000, Stone and colleagues examined the use of
Raman spectroscopy in the detection of laryngeal
malignancy [7]. Fifteen ex-vivo biopsy specimens were
obtained from patients of varying ages (18 to 79 years).
They analyzed three classes of specimen (normal,
dysplastic and squamous cell carcinoma). Their results
demonstrated sensitivities of between 76 and 92%
depending on the tissue type examined and specifici-
ties of over 90%. On further examination, the regions
in the Raman spectra associated with differences
between the tissue types corresponded with protein
bonds and nucleic acids, leading to the discovery that
nucleic acids levels are increased with malignancy. Lau
et al., (2005) undertook a similar study in which 47
laryngeal specimens were interrogated with Raman
spectroscopy [8]. They obtained each spectrum with a
five second acquisition time. The classes of specimen
used were normal, papilloma and carcinoma. Sensitiv-
ities were similar to the study by Stone et al. (69 to
89%), with specificities ranging from 86 to 94%. The
authors determined that spectral differences occurred
in the DNA, amino acids, collagen and glycolipids,
accounting for the ability to discriminate between the
tissue types. Further experimental work on laryngeal
tissue was carried out by Teh and colleagues (2008).
They demonstrated that provided high quality Raman
spectra could be obtained with a collection time of five
seconds, discrimination between cancer and non-can-
cer samples provided a diagnostic sensitivity of 88%
and specificity of 91%.
Figure 3 Human follicular thyroid cells viewed under confocal
microscopy The cells had been stained with Alexa fluor 488
Phalloidin for actin, and To-pro3 for the nuclei.
Figure 4 Human anaplastic thyroid cells viewed under confocal
microscopy. The cells had been stained with Alexa fluor 488
Phalloidin for actin, and To-pro3 for the nuclei.
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Lau et al. (2003) used Raman spectroscopy to classify
tissue obtained from the post-nasal space in cancer and
non-cancer patients [9]. The importance of utilizing
Raman spectroscopy in the nasopharynx is the ability to
detect sub-mucosal tumors associated with this cancer
in this region, preventing the need for random biopsy.
The study was small, observing spectra from six cancer
and six non-cancer patients however, spectral differ-
ences were noted in the regions of the spectra asso-
ciated with collagen, proteins and lipids.
Gniadecka and co-workers (2004) applied Raman
spectroscopy coupled with neural network analysis to
identify skin lesions [10]. Raman spectra were obtained
from 22 melanoma samples, 41 pigmented nevi, 48 basal
cell carcinoma samples, 23 seborrheic keratoses samples,
and 89 normal skin samples. It was found that malig-
nant melanoma could be discriminated from the other
tissue samples based on the amide I protein region
(1660 cm-1) of the spectra; sensitivity and specificity for
melanoma was 85% and 89% respectively.
The main author of this article along with colleagues
assessed the feasibility for Raman spectroscopy coupled
with genetic algorithms to diagnose cancer through a
peripheral blood sample [11]. This has the potential to
revolutionize medical diagnostics with the ability for the
community practitioner to have a diagnosis prior to spe-
cialist referral allowing treatment options to be booked
at the earliest opportunity.
Forty patients in total were tested, twenty with an
established diagnosis of head and neck carcinoma
(although not all squamous cell carcinoma), and twenty
aged-matched controls with respiratory ailments com-
prised the control group. Using a trained genetic algo-
rithm the authors found a 75% sensitivity and 75%
specificity for each cohort. When mixed samples were
used to train the algorithm, the results gave the expected
50% sensitivity and specificity, providing further evidence
that the algorithm was able to discriminate between
cancer and non-cancer samples. The results of 75% are
promising when considering what is being attempted
although further testing of the algorithm with a greater
number of samples and the use of different varieties of
samples is also warranted.
The oral cavity is readily accessible in a clinic setting
and would be ideal for the development of a Raman
probe for cancer detection. Premalignant changes such
as leukoplakia, erythroplakia, and erythro-leukoplakia
are observed and in many cases multiple biopsies are
undertaken with periods of watchful waiting. Malini and
colleagues (2006) studied the ability of Raman spectro-
scopy to discriminate 216 pre-malignant, malignant,
inflammatory and normal tissue samples from the oral
cavity [12]. The discrimination between tissue types was
based on surface findings. Normal healthy cell spectra
originate from the lipid bi-layer, whereas inflammatory
or cancerous cells contain multiple proteins on the cell
surface. Disease sates were also readily distinguishable
when multi-parameter tests were added in conjunction
with principal component analysis.
The Raman analysis of saliva has the potential to
detect malignancy within the oral cavity or orophaynx.
Oral squamous cell carcinoma has a particular poor 5-
year survival rate, approaching 5% [13]. This is mainly
thought to be due to the late presentation of these
tumours. Saliva contains many macromolecules such as
proteins and nucleic acids giving a Raman signature
[14]. However, Raman spectra from saliva are inherently
weak, making interpretation difficult [15]. For this rea-
son enhancement of the Raman signal using a surface-
enhanced approach with gold particles is being studied
[15].
Discussion and Conclusion
As mentioned previously, Raman spectroscopy has a
potential advantage over other optical methods due to its
ability to provide a biochemical ‘fingerprint’. However,
Raman has inherently been associated with a weak signal
and problems with autofluorescence. Autofluorescence is
wavelength dependent and the increased use of incident
photons in the near infrared region of the electromag-
netic spectrum has diminished its effects. The use of
lasers with a greater photon flux intensity can to some
degree overcome a weak signal, also allowing spectra to
be collected within a relatively short time frame in addi-
tion to overcoming the effects of fluorescence. The highly
detailed molecular profile produced by Raman spectro-
scopy can also lead to difficulty with interpretation. Such
accuracy proves difficult to determine causes of spectral
differences, thus more complex data classification models
are being used in an attempt to ‘un-lock’ it’s potential.
Linear discriminant analysis and principal component
analysis are multivariate statistical analysis methods
which are utilized along with partial least square and
non-linear mapping in Raman data analysis [16-20].
However, others are utilizing more complex chemo
metric classification models based around computational
intelligence [21-23]. Until validated methods providing
repeated accuracy on test samples are discovered, this
technique will remain in the research arena.
Optical coherence tomography has recently been used
in-vivo to determine the nature of lesions within the
bladder [24]. These authors found 100% sensitivity with
this optical technique for malignant lesions, also demon-
strating 100% sensitivity for detecting invasion through
the lamina propria. Other authors have been increasing
the accuracy of OCT in cervical neoplasia demonstrat-
ing efficacy within the clinical setting [25]. In their
review article, DeCoro and Wilder-Smith consider the
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possibilities for OCT in oral carcinoma [26]. Infrared
and fluorescence spectroscopy have also been used for
ex-vivo and in-vivo analysis [27-29].
At present the gold standard of cancer diagnosis is
histological assessment. However, this is labour inten-
sive; the specimen needs prior preparation; and is open
to human error. Once a diagnosis of cancer has been
made the patient is discussed at the multi-disciplinary
team (MDT) meeting where clinical staff such as sur-
geons, oncologists, pathologists, and radiologists, and
non-clinical staff; allied health professionals such as
speech therapy and clinical nurse specialists will discuss
appropriate treatment options for the patient. Patients
are then seen in clinic and a definitive treatment plan
agreed. As has been discussed so far early diagnosis
directly affects morbidity and mortality in H&N cancer.
The ability to diagnose malignant disease at the earliest
opportunity allows treatment options to be planned as
early as possible. If the general practitioner could pro-
vide a diagnosis of cancer to the specialist the first
meeting could discuss treatment rather than further
examination, booking for diagnostic biopsy and radiolo-
gical investigations, and then MDT discussion, followed
by treatment.
There has been a paucity of literature regarding Raman
spectroscopy in head and neck cancer detection. How-
ever, others have undertaken in-vivo analysis of malig-
nancies in other body regions [30-33]. Raman has success
in other key health areas such as cardiovascular diseases,
and dental care [34-37]. Following the introduction of
health care targets for cancer, and with an ever-aging
population the need for rapid cancer detection has never
been greater. There is no doubt Raman spectroscopy
could confer great patient benefit with early, rapid and
accurate diagnosis. The authors do not believe optical
diagnostics should replace pathology but aid cancer diag-
nosis. This technique is labour free without the need for
prior sample preparation. It could reduce the need for
whole pathological specimen examination, in theatre it
could help to determine margin status, and finally per-
ipheral blood diagnosis may be an achievable target.
Acknowledgements
The main author would like to thanks Cancer Research UK for funding the
work on Raman spectroscopy in Head and Neck Cancer.
Author details
1Department of Ear, Nose and Throat/Head and Neck Surgery, Calderdale
and Huddersfield NHS Trust, Huddersfield UK. 2Section of Experimental
Therapeutics, Leeds Institute of Molecular Medicine, University of Leeds,
Leeds, UK. 3School of Health Studies, University of Bradford, Bradford, UK.
4Department of Pathology Leeds Dental Institute, University of Leeds, Leeds,
UK. 5Department of Oral Biology, Leeds dental Institute, University of Leeds,
Leeds, UK. 6Department of Otolaryngology with Head & Neck Surgery, Chase
farm Hospital, Enfield, U.K. and Head & Neck Unit UCLH, Euston Road,
London.
Authors’ contributions
AH, AR, SW, HW-U initially drafted the manuscript. SG, DM-H, SF, AH and TU
provided expert surgical and pathological advice. JK provided the
biochemical expertise. All authors made an editorial contribution to the
paper. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 29 July 2010 Accepted: 5 October 2010
Published: 5 October 2010
References
1. Swinson B, Jerjes W, El-Maaytah M, Norris P, Hopper C: Optical techniques
in diagnosis of head and neck cancer. Oral Oncology 2006, 42:221-228.
2. Upile T, Jerjes W, Sterenborg HJCM, El-Naggar AK, Sandison A, Witjes MJH,
Biel MA, et al: Head & Neck optical diagnostics: vision of the future. Head
and Neck Oncology 2009, 1:25.
3. Hanlon EB, Manoharan R, Koo TW, Shafer KE, Motz JT, Fitzmaurice M,
Kramer JR, Itzkan I, Dasari RR, Feld MS: Prospects for in vivo Raman
spectroscopy. Physics in Medicine and Biology 2000, 45:R1-R59.
4. Swain RJ, Steven MM: Raman micro spectroscopy for non-invasive
biochemical analysis of single cells. Biochemical Society Transactions 2007,
35(3):544-549.
5. Harris AT, Garg M, Yang XB, Fisher SE, Kirkham J, Smith DA, Martin-
Hirsch DP, High AS: Raman spectroscopy and advanced mathematical
modelling in the discrimination of human thyroid cell lines. Head and
Neck Oncology 2009, 1:38.
6. Lones MA, Smith SL, Harris AT, High AS, Fisher SE, Smith DA, Kirkham J:
Discriminating Normal and Cancerous Thyroid Cell Lines using Implicit
Context Representation Cartesian Genetic Programming. In Proc. 2010
IEEE Congress on Evolutionary Computation (CEC). Edited by: Fogel G, et al.
IEEE Press; 2010:.
7. Stone N, Stavroulaki P, Kendall C, Birchall M, Barr H: Raman spectroscopy
for early detection of laryngeal malignancy: Preliminary results. The
Laryngoscope 2000, 110:1756-2872.
8. Lau DP, Huang Z, Lui H, Anderson DW, Berean K, Morrison MD, Shen L,
Zeng H: Raman spectroscopy for optical diagnosis in the larnx:
preliminary findings. Lasers in Surgery and Medicine 2005, 37:192-200.
9. Lau DP, Huang Z, Lui H, Man CS, Berean K, Morrison MD, Zeng H: Raman
spectroscopy for optical diagnosis in normal and cancerous tissue of the
nasopharynx - preliminary findings. Lasers in Surgery and Medicine 2003,
32:210-214.
10. Gniadecka M, Philipsen PA, Sigurdsson S, Wessel S, Nielsen OF,
Christensen DH, Hercogova J: Melanoma diagnosis by Raman
spectroscopy and neural networks: structure alterations in proteins and
lipids in intact cancer tissue. Journal of Investigative Dermatology 2004,
122:443-449.
11. Harris AT, Lungari A, Needham CJ, Smith SL, Lones MA, Fisher SE, Yang XB,
Cooper N, Kirkham J, Smith DA, Martin-Hirsch DP, High AS: Potential for
Raman spectroscopy to provide cancer screening using a peripheral
blood sample. Head and Neck Oncology 2009, 1:34.
12. Malini R, Venkatakrishna K, Kurien J, Pai KM, Rao L, Kartha VB, Krishna CM:
Discrimination of normal, inflammatory, premalignant, and malignant
oral tissue: A Raman spectroscopy study. Biopolymers 2006, 81(3):179-193.
13. Reddy SP, Ramaswamy P, Sunanda C, Milanjeet : Role of gold
nanoparticles in early detection of oral cancer. Journal of Indian Academy
of Oral Medicine and Radiology 2010, 22(1):30-33.
14. Nagler RM: Saliva as a tool for oral cancer diagnosis and prognosis. Oral
Oncology 2009, 45:1006-1010.
15. Kah JCY, Kho KW, Lee CGL, Sheppard CJR, Shen ZX, Soo KC, Olivio MC:
Early diagnosis of oral cancer based on the surface Plasmon resonance
of gold nanoparticles. International Journal of Nanomedicine 2007,
2(4):785-798.
16. Notingher I, Jell G, Lohbauer U, Salih V, Hench LL: In situ non-invasive
spectral discrimination between bone cell phenotypes used in tissue
engineering. Journal of Cellular Biochemistry 2004, 92:1180-1192.
17. Notinger I, Jell G, Notingher PL, Bisson I, Tsigkou O, Polak JM, Stevens MM,
Hench LL: Multivariate analysis of Raman spectra for in vitro non-
invasive studies of living cells. Journal of Molecular Structure 2005, 744-
747:179-185.
Harris et al. Head & Neck Oncology 2010, 2:26
http://www.headandneckoncology.org/content/2/1/26
Page 5 of 6
18. Harz M, Kiehntopf M, Stockel S, Rosch P, Deufel T, Popp J: Analysis of
single blood cells for CSF diagnostics via a combination of fluorescence
staining and micro-Raman spectroscopy. Analyst 2008, 133:1416-1423.
19. Krafft C, Knetschke T, Siegner A, Funk RHW, Salzer R: Mapping of single
cells by near infrared Raman microspectroscopy. Vibrational Spectroscopy
2003, 32:75-83.
20. Jarvis R, Broadhurst D, Johnson H, O’Boyle N, Goodacre R: PYCHEM: a
multivariate analysis package for python. Bioinformatics 2006,
22:2565-2566.
21. Jarvis RM, Goodacre R: Genetic algorithm optimization for pre-processing
and variable selection of spectroscopic data. Bioinformatics 2005,
21(7):860-868.
22. Vaidyanathan S, Broadhurst DI, Kell DB, Goodacre R: Explanatory
optimization of protein mass spectrometry via genetic search. Analytical
Chemistry 2003, 75:6679-6686.
23. Goodacre R, Neal MJ, Kell DB: Rapid and quantitative analysis of the
pyrolysis mass spectra of complex binary and tertiary mixtures using
multivariate calibration and artificial neural networks. Analytical Chemistry
1994, 66:1070-1085.
24. Karl A, Stepp H, Willmann E, Buchner A, Hocaoglu Y, Stief C, Tritschler S:
Optical oherence tomography for bladder cancer - ready as a surrogate
for optical biopsy? - results of a prospective mono-centre study.
European Journal of Medical Research 2010, 15(3):131-134.
25. Liu ZH, Belinson SE, Li J, Yang B, Na WL, Tresser NJ, Wang C, Mohr M, et al:
Diagnostic Efficacy of Real-Time Optical Coherence Tomography in the
Management of Preinvasive and Invasive Neoplasia of the Uterine
Cervix. International Journal of Gynecological Cancer 2010, 20(2):283-287,
Krafft S.
26. DeCoro M, Wilder-Smith P: Potential of optical coherence tomography for
early diagnosis of oral malignancies. Expert review of anticancer therapy
2010, 10(3):321-329.
27. Madhuri S, Vengadesan N, Aruna P, Koteeswaran D, Ventatesan P,
Ganesan S: Native fluorescence spectroscopy of blood plasma in the
characterization of oral malignancy. Photochemistry and Photobiology
2003, 78(2):197-204.
28. Lasch A, Haensch W, Lwis N, Kidder LH, Naumann D: Characterization of
colorectal adenocarcinoma sections by spatially resolved FT-IR
microscpectroscopy. Applied Spectroscopy 2002, 56:1-9.
29. Wood BR, Chiriboga L, Yee H, Quinn MA, McNaughton D, Diem M: FTIR
mapping of the cervical transformation zone, squamous and glandular
epithelium. Gynecologic Oncology 2004, 93(4):59-68.
30. Haka A, Volynskaya Z, Gardecki J, Nazemi J, Lyons J, Hicks D, Fitzmaurice M,
Dasari R, Crowe J, Feld M: In vivo margin assessment during partial
mastectomy breast surgery using Raman spectroscopy. Cancer Research
2006, 66:3317-3322.
31. Moncrieff M, Cotton S, Claridges E, Hall P: Spectrophotometric
intracutaneous analysis: a new technique for imaging pigmented skin
lesions. British Journal of Dermatology 2002, 146:448-457.
32. Molckovsky A, Song LM, Shim MG, Marcon NE, Wilson BC: Diagnostic
potential of near-infrared Raman spectroscopy in the colon:
differentiating adenomatous from hyperplastic polyps. Gastrointestinal
Endoscopy 2003, 57:396-402.
33. Chowdary M, Kumar K, Mathew S, Roa L, Krishna M, Kurien J: Biochemical
correlation of Raman spectra of normal, benign and malignant breast
tissues: A spectral deconvolution study. Biopolymers 2009, 91:539-546.
34. Motz JT, Fitzmaurice M, Miller A: In vivo Raman spectral pathology of
human atherosclerosis and vulnerable plaque. Journal of Biomedical
Optics 2006, 11(2):0210031-9.
35. Buschman HP, Marple ET, Wach ML, Bennett B, Bakker Schut TC,
Bruining HA, Bruschke AV, et al: In Vivo determination of the molecular
composition of artery wall by intravascular Raman spectroscopy.
Analytical Chemistry 2000, 72:3771-3775.
36. Utzinger U, Richards-Kortum R: Fibre optic probes for biomedical
spectroscopy. Journal of Biomedical Optics 2003, 8:121-147.
37. Choo-Smith LP, Hewko M, Sowa MG: Emerging Raman Applications and
Techniques in Biomedical and Pharmaceutical Fields. Emerging Dental
Applications of Raman Spectroscopy 2010, 263-284.
doi:10.1186/1758-3284-2-26
Cite this article as: Harris et al.: Raman spectroscopy in head and neck
cancer. Head & Neck Oncology 2010 2:26.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Harris et al. Head & Neck Oncology 2010, 2:26
http://www.headandneckoncology.org/content/2/1/26
Page 6 of 6
